The consultant in charge of the patient should be notified in each case
before a patient with an acute stroke has their blood pressure actively lowered Principle & background Early (30 day) mortality is about 10% in cerebral infarction: o Risk is greatest if Systolic BP 130mm!g and"or #iastolic BP $0mm!g Early (30 day) mortality is about %0% in intracerebral &emorr&age o Risk is greatest if Systolic BP ' 1(0mm!g and"or #iastolic BP ' 1%0mm!g )&ese are only associations and in most cases lo*ering t&e BP *ill +otentially e,tend t&e stroke area and *orsen t&e +atient-s condition. BP generally returns to baseline o/er 012$% &ours. WHEN TO TREAT t!ese are opinion based recommendations as proper e"idence for ideal treatment does not e#ist at t!is time $sc!aemic Stroke 1. 3o t&rombolysis +lanned 4 treat if SBP 5%%0 6"2 #BP 51%0 mm!g %. 7f t&rombolysis +lanned 4 treat if SBP 51(0 6"2 #BP 5110 mm!g 8im: 9o*er BP by 1021:% only $ntracerebral Haemorr!age 1. #iscuss *it& consultant *&et&er intracerebral +ressure (7;P) monitoring is +lanned if so< aim for cerebral +erfusion +ressure (;PP) (=>8P 4 7;P) 5 ?0 mm!g %. 7f 7;P monitoring not +lanned aim for SBP 1:021?0 mm!g and >8P 11021%0 mm!g (>8P = 1"3 SBP 6 %"3 #BP) Subarac!noid Haemorr!age %SAH& 7f +atient alert (;PP is likely to be normal) lo*er SBP to around 100 mm!g 7f unconscious 4 do 3@) lo*er BP in 1 st 0&rs HOW TO TREAT BP in t&is setting is ty+ically labile and intra/enous treatment as belo* is more likely to ac&ie/e smoot& BP control t&an oral medications as absor+tion and action are less +redictable. HYDRALAZINE 1. Begin with bolus doses 5mg ivi 20-30 minutes apart to a maximum of 3 doses. If BP rises again despite this then use infusion as below 2. !"drala#ine infusion $%0 mg in 500 m& '(saline) * 1-5 mg(hr $+- 30 ml(hr) Side effects: Alus&ing< tac&ycardia< &eadac&e METOPROLOL #ose: : mg bolus gi/en o/er %23 mins Re+eat at : minute inter/als u+ to ma,imum %0 mg >onitor *it& E;B during treatment Ensure no contraindications to C2blockers E,creted renally so *atc& for bradycardia in +atients *it& renal failure. Sodium 3itro+russide is also an e,cellent drug to use in t&is setting if a++ro+riate monitoring is a/ailable ( see table of nitro+russide use in D)reatment of &y+ertensi/e emergency-) Note: when withdrawing hydralazine, metoprolol or nitroprusside this should be done by reducing the infusion rate or bolus schedule slowly over hours and overlapping with oral antihypertensives Selected references: ;astillo et al. Stroke. %000E3:::%02? @li/eira2Ail&o et al. 3eurology. %003E?1:103021 Fillmot et al.!y+ertension.%000E03:112%0 @kumura et al. G !y+ertension. %00:E%3:1%1$2%3 H+)o#ate online